Nagai R - Search Results

1

Induction of virus-induced IDDM in virus resistant mice without lymphocyte maturation.

Kanda T, Utsugi T, Kawazu S, Wilson JE, Yang D, Suarez A, McManus BM, Nagai R, Kobayashi I. Kanda T, et al. Among authors: nagai r. Life Sci. 1998;63(1):33-40. doi: 10.1016/s0024-3205(98)00233-1. Life Sci. 1998. PMID: 9667762

2

Modification of viral myocarditis in mice by interleukin-6.

Kanda T, McManus JE, Nagai R, Imai S, Suzuki T, Yang D, McManus BM, Kobayashi I. Kanda T, et al. Among authors: nagai r. Circ Res. 1996 May;78(5):848-56. doi: 10.1161/01.res.78.5.848. Circ Res. 1996. PMID: 8620605

3

Interleukin-6 secreted from human myxoma reduces murine viral myocarditis.

Kanda T, Sakamoto H, McManus BM, Sakamaki T, Nagai R, Suzuki T, Kobayashi I. Kanda T, et al. Among authors: nagai r. Life Sci. 1996;58(20):1705-12. doi: 10.1016/0024-3205(96)00150-6. Life Sci. 1996. PMID: 8637394

4

Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.

Kanda T, Kogure S, Nara M, Tsukui S, Utsugi T, Tomono S, Kawazu S, Nagai R, Kobayashi I. Kanda T, et al. Among authors: nagai r. Eur J Pharmacol. 1998 Jan 26;342(2-3):297-302. doi: 10.1016/s0014-2999(97)01476-3. Eur J Pharmacol. 1998. PMID: 9548400

5

Heat stress aggravates viral myocarditis in mice.

Kanda T, Nakano M, Yokoyama T, Hoshino Y, Okajima F, Tanaka T, Saito Y, Nagai R, Kobayashi I. Kanda T, et al. Among authors: nagai r. Life Sci. 1999;64(2):93-101. doi: 10.1016/s0024-3205(98)00539-6. Life Sci. 1999. PMID: 10069487

6

Increased severity of viral myocarditis in mice lacking lymphocyte maturation.

Kanda T, Koike H, Arai M, Wilson JE, Carthy CM, Yang D, McManus BM, Nagai R, Kobayashi I. Kanda T, et al. Among authors: nagai r. Int J Cardiol. 1999 Jan;68(1):13-22. doi: 10.1016/s0167-5273(98)00250-2. Int J Cardiol. 1999. PMID: 10077396

7

Oral administration of branched chain amino acids improves virus-induced glucose intolerance in mice.

Utsugi T, Yoshida A, Kanda T, Kobayashi I, Kurabayashi M, Tomono S, Kawazu S, Tajima Y, Nagai R. Utsugi T, et al. Among authors: nagai r. Eur J Pharmacol. 2000 Jun 23;398(3):409-14. doi: 10.1016/s0014-2999(00)00221-1. Eur J Pharmacol. 2000. PMID: 10862831

8

Effect of interleukin-18 on viral myocarditis: enhancement of interferon- gamma and natural killer cell activity.

Kanda T, Tanaka T, Sekiguchi K, Seta Y, Kurimoto M, Wilson McManus JE, Nagai R, Yang D, McManus BM, Kobayashi I. Kanda T, et al. Among authors: nagai r. J Mol Cell Cardiol. 2000 Dec;32(12):2163-71. doi: 10.1006/jmcc.2000.1242. J Mol Cell Cardiol. 2000. PMID: 11112992

9

A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.

Takahashi T, Kanda T, Inoue M, Suzuki T, Kobayashi I, Kodama K, Nagai R. Takahashi T, et al. Among authors: nagai r. Life Sci. 1996;59(23):PL 371-7. doi: 10.1016/s0024-3205(96)00554-1. Life Sci. 1996. PMID: 8950302

10

Effect of amrinone on murine viral myocarditis.

Seta Y, Kanda T, Yokoyama T, Kobayashi I, Suzuki T, Nagai R. Seta Y, et al. Among authors: nagai r. Res Commun Mol Pathol Pharmacol. 1997 Jan;95(1):57-66. Res Commun Mol Pathol Pharmacol. 1997. PMID: 9055349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,793 results

Search Page

Filters